Aelius Biotech
The company provides specialized gastrointestinal modelling services through its proprietary MuCo platform to simulate dissolution, digestion, and absorption. They offer in vitro models and human trial services to help biotech, pharmaceutical, and nutraceutical companies de-risk product development. Their technology specifically focuses on the role of mucus and bile in the digestive process to provide physiologically relevant data.
Visit websiteNewcastle upon Tyne, UK
Biotech
Pharmaceuticals
Nutraceuticals
Food Technology
Life Sciences
Funding summary
- Total raised
- €2.3M
- Funding rounds
- 2
Investors in Aelius Biotech
Investors on record for Aelius Biotech. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Aelius Biotech?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors